Reimagining Alzheimer’s, New Insights Challenge the Amyloid Plaque Paradigm

For decades, the medical community has held a steadfast belief: amyloid plaques in the brain are the primary culprits behind Alzheimer's disease. This theory has driven numerous research efforts and drug developments aimed at reducing these plaques to combat cognitive decline. However, a groundbreaking study led by Alberto Espay at the University of Cincinnati is challenging this..........